title: Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application.
authors.forename: J-H
authors.initials: JH
authors.lastname: Lee
authors.forename: A-L
authors.initials: AL
authors.lastname: Cheng
authors.forename: C-W
authors.initials: CW
authors.lastname: Lin
authors.forename: S-H
authors.initials: SH
authors.lastname: Kuo
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D054446:Lymphoma, Primary Cutaneous Anaplastic Large Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016328:NF-kappa B / Q000187:drug effects; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D016328:NF-kappa B; D013792:Thalidomide